# Atonco

> Atonco développe l'ATO\-101™, un radiopharmaceutique à base d'astate\-211 pour traiter le cancer de la vessie non\-musculo\-invasif résistant au BCG\.

Generated by Yoast SEO v27.4, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Contact](https://atonco-pharma.com/contact/)
- [Contact](https://atonco-pharma.com/contact/)
- [Technologie](https://atonco-pharma.com/technologie/)
- [AtoncoHome](https://atonco-pharma.com/)
- [À propos](https://atonco-pharma.com/a-propos/)

## Articles
- [Le nouveau numéro d'ImmunoWatch de MabDesign consacré aux produits radiopharmaceutiques est désormais disponible \!](https://atonco-pharma.com/2026/07/21/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible/)
- [ATONCO ANNOUNCES THE APPOINTMENT OF DR\. ALEXANDRA \(GITEAU\) PAILLARD AS CHIEF OPERATING OFFICER](https://atonco-pharma.com/2025/10/24/atonco-annonce-la-nomination-du-dr-alexandra-giteau-paillard-au-poste-de-directrice-des-operations-chief-operating-officer/)
- [ATONCO AIMS TO REVOLUTIONIZE BLADDER CANCER TREATMENT](https://atonco-pharma.com/2025/09/23/atonco-veut-revolutionner-le-traitement-du-cancer-de-la-vessie/)
- [TOWARDS NEW, MORE TARGETED WAYS OF TREATMENT](https://atonco-pharma.com/2025/10/22/vers-de-nouvelles-facons-de-soigner-plus-ciblees/): Bérénice Robert dans La Recherche trimestriel n°583 \- Octobre\-Décembre 2025
- [CLINICAL ALPHATHERAPY STATUS – NOVEMBER 2025](https://atonco-pharma.com/2025/11/20/alphatherapie-clinique-novembre-2025/)

## Science
- [Non\-Muscle\-Invasive Bladder Cancer Unresponsive to BCG: Alpha Therapy as Compared to Chemotherapy and Immunotherapy Including Gene Therapy](https://atonco-pharma.com/science/non-muscle-invasive-bladder-cancer/): This article reviews current and emerging therapeutic options for BCG\-unresponsive non\-muscle\-invasive bladder cancer, with a particular focus on the potential of targeted alpha therapy compared with chemotherapy, immunotherapy, and gene therapy\.
- [Non\-Muscle\-Invasive Bladder Cancer Unresponsive to BCG: Alpha Therapy as Compared to Chemotherapy and Immunotherapy Including Gene Therapy](https://atonco-pharma.com/science/non-muscle-invasive-bladder-cancer/): Cet article passe en revue les options thérapeutiques actuelles et émergentes pour les tumeurs de la vessie non infiltrant le muscle \(TVNIM\) et ne répondant pas au BCG, en mettant particulièrement l'accent sur le potentiel de l'immuno alphathérapie par rapport à la chimiothérapie, à l'immunothérapie et à la thérapie génique\.

- [PERTINENCE – 89Zr\-Girentuximab Imaging in Non\-Muscle\-Invasive Bladder Cancer](https://atonco-pharma.com/science/pertinence-89zr-girentuximab-imaging-in-non-muscle-invasive-bladder-cancer/): ClinicalTrials\.gov ID NCT04897763 – Sponsor Institut Cancerologie de l'Ouest – ClinicalTrials\.gov – NCT04897763
- [211At\-BC8\-B10 Before Donor Stem Cell Transplant in Treating Patients With High\-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed\-Phenotype Acute Leukemia](https://atonco-pharma.com/science/211at-bc8-b10-before-donor-stem-cell-transplant-in-treating-patients-with-high-risk-acute-myeloid-leukemia-acute-lymphoblastic-leukemia-myelodysplastic-syndrome-or-mixed-phenotype-acute-leukemia/):  ClinicalTrials\.gov ID: NCT03128034 \- Sponsor: Fred Hutchinson Cancer Center \- ClinicalTrials\.gov Link: https://clinicaltrials\.gov/study/NCT03128034
- [Development of PSMA\-Targeted Alpha Therapy Using \[211At\]PSMA\-5](https://atonco-pharma.com/science/development-of-psma-targeted-alpha-therapy-using-211atpsma-5/): Watabe, T\.; Naka, S\.; Shirakami, Y\.; Kaneda, K\.; Murakami, M\.; Toyoshima, A\.; Cardinale, J\.; Giesel, F\.L\. Development of PSMA\-Targeted Alpha Therapy Using \[211At\]PSMA\-5\. Seminars in Nuclear Medicine 2025;55\(6\):947\-954\. DOI: 10\.1053/j\.semnuclmed\.2025\.09\.005


## Carrières
- [Open Application](https://atonco-pharma.com/carrieres/candidature-spontanee/)
- [Candidature spontanée](https://atonco-pharma.com/carrieres/candidature-spontanee/)

## Catégories
- [Communiqués de presse Atonco](https://atonco-pharma.com/category/press-release-atonco/)
- [Autres actualités](https://atonco-pharma.com/category/autres-news/)

## Categories Science
- [Publications At\-211](https://atonco-pharma.com/science_category/alpha-therapie/)
- [Publications ATO\-101™](https://atonco-pharma.com/science_category/atonco/)

## Optional
- [Sitemap index](https://atonco-pharma.com/sitemap_index.xml)